证券记录 · 已归档季度
OPK
OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research
12被追踪持有人
+1Δ持有人
38.88M持有股份
$64.54M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +9.1% ·
股份流向 +29.5% ·
净新建仓位 +8.3%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -5 | 114.41M | $171.44M | +3 | −8 |
| Q1 2026 | 91 | +2 | 116.06M | $132.34M | +8 | −6 |
| Q4 2025 | 88 | 0 | 132.71M | $167.24M | +1 | −1 |
| Q3 2025 | 15 | -2 | 100.01M | $155.02M | — | −3 |
| Q2 2025 | 15 | 0 | 96.47M | $127.34M | +2 | −2 |
| Q1 2025 | 12 | +1 | 38.88M | $64.54M | +2 | −1 |
| Q4 2024 | 11 | -1 | 30.02M | $44.13M | — | −1 |
| Q3 2024 | 11 | +1 | 16.46M | $24.53M | +1 | — |
| Q2 2024 | 10 | — | 13.40M | $16.75M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 8.43M | +0.5% | $14.00M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 8.43M | +0.5% | $14.00M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 8.14M | -10.3% | $13.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 6.39M | +39.2% | $10.60M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Marshall Wace ✦ | 4.90M | +431.4% | $8.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Marshall Wace ✦ | 4.90M | +431.4% | $8.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 4.73M | 新增 | $7.85M | 0.0% | New | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.86M | -42.2% | $3.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.86M | -42.2% | $3.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 1.65M | -0.1% | $2.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 1.65M | -0.1% | $2.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.61M | +466.7% | $2.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 1.61M | +466.7% | $2.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 1.61M | +466.7% | $2.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.61M | +466.7% | $2.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.61M | +466.7% | $2.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 501.67K | +10.1% | $833,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Norges Bank ✦ (被动) | 494.26K | -56.2% | $820,467 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 175.00K | 0.0% | $290,500 | 0.0% | Held | 4 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 11.06K | 新增 | $18,353 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $7.85M | 0.0% |
| Gotham Asset Management | $18,353 | 0.0% |
已清仓
| Renaissance Technologies | $214,586 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 231 持有人, 200.30M 股份, $226.79M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据